Definitions

Sorry, no definitions found. You may find more data at trimeris.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word Trimeris.

Examples

  • Trimeris, Inc. (Nasdaq: TRMS) ( "Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co.,

    THE MEDICAL NEWS 2009

  • (Nasdaq: TRMS) ( "Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co.,

    FinanzNachrichten.de: Aktuelle Nachrichten 2009

  • Trimeris, Inc. (Nasdaq: TRMS) ( "Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co.,

    THE MEDICAL NEWS 2009

  • DURHAM, N.C. - (Business Wire) Trimeris, Inc. (Nasdaq: TRMS) ( "Trimeris") today announced that in connection with the Agreement and Plan of Merger dated October 2, 2009, as amended, by and among Trimeris, Arigene Co.,

    The Earth Times Online Newspaper 2009

  • ThinkEquity Partners initiated coverage on Trimeris on Feb. 23 with a "sell" rating.

    Eye On Stocks For Friday, March 10, 2006Eye On Stocks For Friday, March 10 2006

  • Trimeris shares jumped 10% in after-hours trading after the tiny biotech firm said it turned a quarterly profit for the first time, driven by strong sales of Fuzeon, an HIV drug co-marketed by Roche.

    Eye On Stocks For Friday, March 10, 2006Eye On Stocks For Friday, March 10 2006

  • Trimeris is designing large, final-stage testing of T-20.

    ANC Daily News Briefing 2000

  • As previously reported, Trimeris entered into a new royalty arrangement with F.

    unknown title 2011

  • Completion of the Synageva Merger is subject to various conditions, including the approval of the stockholders of both Trimeris and Synageva.

    unknown title 2011

  • Although worldwide net sales of FUZEON during the quarter ended June 30, 2011 increased $1.7 million from worldwide net sales of FUZEON in the quarter ended March 31, 2011, Trimeris believes that this quarter-to-quarter increase in net sales is more likely due to the continuation of historical variability in FUZEON sales rather than stabilization of the recent decline in net sales of FUZEON.

    unknown title 2011

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.